Substantial individual differences exist in the magnitude of the cognitive decline associated with normal aging. Potential contributors to this intersubject variability include white matter hyperintensities (WMH) and preclinical Alzheimer′s disease, evident as increased brain amyloid. This study examined whether older individuals with minimal evidence of WMH and/or brain amyloid-beta (seen on positron emission tomography with the Pittsburgh compound B radiotracer-PiB) still showed significant cognitive decrements compared to the young. Older individuals, conservatively screened for normal range performance on an extensive neuropsychological battery, underwent structural magnetic resonance imaging (MRI) and PiB scans and performed tests of information processing speed, working memory and inhibitory function. The elderly were divided into PiB(+) and PiB( À ) groups based on radiotracer retention. There were no significant differences in cognitive performance between PiB(+) and PiB( À ) elderly. However, both PiB groups performed significantly worse than did the young on cognitive testing. WMH burden in the same individuals was quantified by consensus ratings using a 10 point scale with a median split defining two groups, WMH(+) and WMH( À ). There were no differences in cognitive performance between WMH(+) and WMH( À ) individuals, but both WMH groups performed significantly worse than did the young. Older participants who were both PiB( À ) and WMH( À ) also performed significantly worse than did the young in all three cognitive domains. The present results suggest that normal-elderly individuals whose brain scans show minimal evidence of amyloid deposition or WMH, still demonstrate a major decrement in comparison to younger persons on measures of processing resources and inhibitory efficiency.
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Introduction
A large literature documents the decline in cognitive performance associated with increasing age (Rabbitt, 2002) . This is commonly thought to reflect an intrinsic deterioration over time in the complex neurological systems responsible for cognition, described by Drachman (2006) as being the "biologic manifestations of increasing entropy". However, there are substantial betweenperson differences in the magnitude of this age-associated cognitive impairment (Ardila, 2007) . Potential sources for some of this intersubject variability have emerged from brain-imaging studies showing structural evidence of white matter abnormalities in the form of white matter hyperintensities (WMH) in the majority of older persons, despite the absence of clinical symptoms of major cerebrovascular disease (Longstreth et al., 1996) . These WMH are associated with poorer cognitive performance in putatively normal elderly persons (Gunning-Dixon & Raz, 2000; Rabbitt et al., 2007; Söderlund et al., 2006) suggesting that some of the cognitive decrements ascribed to normal aging may reflect extrinsic ageassociated disease, possibly of vascular origin.
Another possible contributor to the cognitive problems found in the elderly is preclinical Alzheimer′s disease (AD) (Sperling et al., 2011) . The risk for AD increases with advancing age and its onset is insidious, producing a decline in cognitive functioning long before the disease can be clinically detected (Bäckman, Jones, Berger, Laukka, & Small, 2005 
